Advances in the Lung Cancer Immunotherapy Approaches

Despite the progress in the comprehension of LC progression, risk, immunologic control, and treatment choices, it is still the primary cause of cancer-related death. LC cells possess a very low and heterogeneous antigenicity, which allows them to passively evade the anticancer defense of the immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Padinharayil, Hafiza, Alappat, Reema Rose, Joy, Liji Maria, Anilkumar, Kavya V., Wilson, Cornelia M., George, Alex, Valsala Gopalakrishnan, Abilash, Madhyastha, Harishkumar, Ramesh, Thiyagarajan, Sathiyamoorthi, Ezhaveni, Lee, Jintae, Ganesan, Raja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693102/
https://www.ncbi.nlm.nih.gov/pubmed/36423060
http://dx.doi.org/10.3390/vaccines10111963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693102/
https://www.ncbi.nlm.nih.gov/pubmed/36423060
http://dx.doi.org/10.3390/vaccines10111963

Ejemplares similares